KOX2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-79449
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human KOX2. Peptide Sequence LQKGDKGEKHFECNECGKAFWEKSHLTRHQRVHTGQKPFQCNECEKAFWD. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for KOX2 Antibody
![Western Blot: KOX2 Antibody [NBP1-79449]](https://resources.bio-techne.com/images/products/KOX2-Antibody-Western-Blot-NBP1-79449-img0002.jpg "Western Blot: KOX2 Antibody [NBP1-79449]")
Western Blot: KOX2 Antibody [NBP1-79449]
Western Blot: KOX2 Antibody [NBP1-79449] - Hela cell lysate, concentration 0.2-1 ug/ml.Applications for KOX2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KOX2
Alternate Names
KOX2, KOX31, zinc finger protein 11A, zinc finger protein 33A, zinc finger protein KOX31, ZNF11, ZZAPK
Gene Symbol
ZNF33A
UniProt
Additional KOX2 Products
Product Documents for KOX2 Antibody
Product Specific Notices for KOX2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...